
|Articles|March 21, 2008
FDA sends early warning of Spiriva's potential stroke risk
Tiotropium bromide is associated with possible increased risk of stroke
Advertisement
The long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) with Boehringer Ingelheim's
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Bipartisan Legislation Aims to Address Consolidation and Vertical Integration of PBMs
2
FDA Reaffirms Strict Regulations Amid GLP-1 Compounding Concerns
3
Tryptyr Increases Tear Production in Dry Eye Disease
4
FDA Removes Black Box Warning on 6 Menopausal Hormone Therapy Products
5




































